| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |